medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 05

<< Back Next >>

Ginecol Obstet Mex 2016; 84 (05)

Active management of the third stage of labor: Three schemes of oxytocin: randomised clinical trial

Neri-Mejía M, Pedraza-Avilés AG
Full text How to cite this article

Language: Spanish
References: 15
Page: 306-313
PDF size: 427.36 Kb.


Key words:

Postpartum hemorrhage, oxytocin, uterotonic, pregnancy complications, active management.

ABSTRACT

Objetive: To compare the effectiveness of intramuscular oxytocin against intravenous oxytocin against intravenous traditional oxytocin infusion, in the active management of the third period of the delayed impingement labor work and controlled cord traction.
Methods: Randomized controlled blinded clinical trial. In women age 14 to 40 with full term pregnancy, childbirth attended by ISSSTE´s Regional Hospital “Gral. Ignacio Zaragoza”, in the period from August to December 2015.
Results: 152 deliveries were attended, from which 66 fulfill with selection criteria. Group 1 = 22 patients, group 2 = 21 patients and Group 3 = 23 patients. The total age average was 26.92 + 5.8. For blood volume, statistical differences were significant among the three groups (p = 0.000). Adverse reactions were presented in 1.5%, without difference between the groups. (P = 0.337). The differences in hemoglobin values and final and initial hematocrit presented differences with statistical significance (p = 0.000 for both).
Conclusions: Nonetheless, the differences obtained in the analysis of the diverse variables among the three types of treatment, the three schemes are effective on the obstetrical hemorrhage prevention.


REFERENCES

  1. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006 Apr 1; 367 (9516):1066–74.

  2. Organización Mundial de la Salud. Recomendaciones de la OMS para la prevención y el tratamiento de la hemorragia posparto [Internet]. Suiza; 2014. (Citado 9 Feb 2016). Disponible en: http://www.who.int/reproductivehealth/ publications/maternal_perinatal_health/ pph-key-messages/es/

  3. Leduc D, Senikas V, Lalonde AB, Ballerman C, Biringer A, Delaney M, et al, Clinical Practice Obstetrics Committee; Society of Obstetricians Gynaecologists of Canada. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can 2009 Oct; 31(10):980–993.

  4. Afolabi EO, Kuti O, Orji EO, Ogunniyi SO. Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labour. Singapore Med J. 2010; 51(3): 207- 210.

  5. Dahlke JD, Mendez-Figueroa H, Maggio L, Hauspurg AK, Sperling JD, Chauhan SP, et al. Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines. Am J Obstet Gynecol [Internet]. Elsevier Inc.; 2015; 1–10. Disponible en: http://linkinghub.elsevier.com/ retrieve/pii/S0002937815001593

  6. Diagnóstico y Tratamiento de la Hemorragia Obstétrica en la Segunda Mitad del Embarazo y Puerperio Inmediato. México: Secretaria de Salud; 2009. (Citado 16 Feb 2016). Disponible en: http://www.cenetec.salud.gob.mx/descargas/ gpc/CatalogoMaestro/162_GPC_HEMORRAGIA_OBSTETRICA/ Imss_162ER.pdf

  7. Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S. Prospective randomized trial of oxytocin administration for active management of the third stage of labor. Int J Gynecol Obstet [Internet]. 2014; 127(2):175-9. Disponible en: http://linkinghub.elsevier.com/retrieve.

  8. Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Syst Rev. 2013; 10:CD001808. doi: 10.1002/14651858.CD001808.pub2. Review.

  9. Aziz S, Kazi S, Haq G, Soomro N. Oral misoprostol versus oxytocin in the management of third stage of labour. J Pak Med Assoc 2014 Apr; 64(4):428-432.

  10. Oladapo OT, Okusanya BO, Abalos E: Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD009332. DOI: 10.1002/14651858. CD009332.pub2.

  11. Sheldon WR, Durocher J, Winikoff B, Blum J, Trussell J, How effective are the components of active managment of third stage of labor? BMC Pregnancy Childbirth. 2013 Feb 21; 13:46. doi: 10.1186/1471-2393-13-46.

  12. Puri M, Taneja P, Gami N, Rehan HS. Effects of different doses of intraumbilical oxytocin on the third stage of labor. Int J Gynaecol Obstet. 2012 Sep; 118(3):210-2. doi: 10.1016/j.ijgo.2012.04.010.

  13. Ozdegirmenci O, Erkaya S, Yalvac S, Dilbaz B, Altinbas S, Haberal A. Does early repair of episiotomy decrease postpartum blood loss: a randomized clinical trial. J Matern Fetal Neonatal Med 2010; Apr 23(4):308–10

  14. Phillip H, Fletcher H, Reid M. The impact of induced labour on postpartum blood loss. J Obstet Gynaecol 2004; 24(1):12–5.

  15. Belghiti J, Kayem G, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C. Oxytocin during labour and risk of severe postpartum haemorrhage: a population-based, cohort-nested case-control study. BMJ Open 2011 Dec 21; 1(2):e000514. doi: 10.1136/bmjopen-2011-000514. Print 201.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2016;84